Laish-Farkash Avishag, Sevilya Ziv, Perelshtein Brezinov Olga, Fortis Lior, Lev Eli
Cardiology Department, Samson Assuta Ashdod University Medical Center, Ashdod, and Ben Gurion University of the Negev, Israel.
Int J Cardiol Cardiovasc Risk Prev. 2022 Oct 25;15:200155. doi: 10.1016/j.ijcrp.2022.200155. eCollection 2022 Dec.
The CHADS-VASc score was shown to predict systemic thromboembolism and mortality in certain groups of patients in sinus rhythm (SR). Previous data showed that patients in SR with high CHADS-VASc score have higher plasma levels of inflammatory markers such as sP-selectin and -reactive protein. We further investigated this group.
Blood samples were collected from consecutive patients in SR. Plasma was extracted and stored at -80 °C. Concentrations of a panel of soluble markers IL-1β, IL-6, IL-8, IL-10, TNF-α and VEGF were measured by Magnetic Luminex Performance Assay. The PLF4 cytokine blood level was measured by ELISA.
66 patients were enrolled (age 53 ± 18 years, 60% women). Patients with high CHADS-VASc scores (n = 23) had significantly higher median IQR concentrations of TNF-α [10.34 (8.55,14.92) vs. 7.69 (6.06, 9.85) pg/ml, p = 0.009] and a trend towards higher levels of IL-1β [0.59 (0.4,0.8) vs. 0.44 (0.31, 0.62) pg/ml, p = 0.07] and IL-8 [5.92 (4.5,9.4) vs. 5.04 (3.63, 6.04) pg/ml, p = 0.07], compared to the group with low scores (n = 43). Median IQR concentrations of VEGF, IL-6, IL-10 and PF4 did not significantly differ between the CHADS-VASc score groups.
Patients in SR with high versus low CHADS-VASc scores have high plasma concentrations of systemic inflammation cytokines. The already proven high levels of sP-selectin, that promotes release of inflammatory cytokines from leukocytes, is in line with these results. This pro-inflammatory state in patients with high CHADS-VASc scores, may explain the higher rate of adverse cardiovascular events associated with elevated CHADS-VASc score even without atrial fibrillation.
CHADS-VASc评分已被证明可预测某些窦性心律(SR)患者群体的系统性血栓栓塞和死亡率。既往数据显示,CHADS-VASc评分高的SR患者血浆中炎症标志物如可溶性P选择素和C反应蛋白水平较高。我们进一步对该群体进行了研究。
收集连续的SR患者的血样。提取血浆并储存在-80°C。通过磁珠法检测一组可溶性标志物白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)和血管内皮生长因子(VEGF)的浓度。通过酶联免疫吸附测定法检测血小板因子4(PF4)细胞因子的血药浓度。
共纳入66例患者(年龄53±18岁,60%为女性)。CHADS-VASc评分高的患者(n = 23)与评分低的患者(n = 43)相比,TNF-α的中位数四分位间距浓度显著更高[10.34(8.55,14.92)对7.69(6.06,9.85)pg/ml,p = 0.009],IL-1β[0.59(0.4,0.8)对0.44(0.31,0.62)pg/ml,p = 0.07]和IL-8[5.92(4.5,9.4)对5.04(3.63,6.04)pg/ml,p = 0.07]水平有升高趋势。CHADS-VASc评分组之间VEGF、IL-6、IL-10和PF4的中位数四分位间距浓度无显著差异。
CHADS-VASc评分高的SR患者与评分低的患者相比,血浆中全身炎症细胞因子浓度较高。已证实的高水平可溶性P选择素可促进白细胞释放炎症细胞因子,这与这些结果一致。CHADS-VASc评分高的患者的这种促炎状态,可能解释了即使没有心房颤动,CHADS-VASc评分升高与不良心血管事件发生率较高之间的关系。